Mark Ma

Amgen (United States)

Papers

1

Total Citations

11

H-Index

1

About

Mark Ma is a distinguished researcher in bioanalytical chemistry, with a primary focus on electrochemiluminescence (ECL) platforms and their applications in macromolecular analysis. His most cited work, "Applications of a planar electrochemiluminescence platform to support regulated studies of macromolecules: Benefits and limitations in assay range" (2009), has garnered 11 citations, establishing foundational insights into the practical use of ECL for regulated bioanalysis. Ma's major contributions lie in elucidating the benefits and constraints of planar ECL systems, particularly in expanding assay range for large biomolecules—a critical advancement for pharmaceutical and diagnostic industries. His research bridges the gap between innovative detection technologies and regulatory compliance, enabling more robust and reliable macromolecular studies. Through his work, Ma has helped shape best practices for implementing ECL in high-throughput environments, influencing both academic research and industrial applications. His achievements underscore a commitment to improving analytical sensitivity and reproducibility, making him a key figure in the evolution of bioanalytical methods.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Applications of a planar electrochemiluminescence platform to support regulated studies of macromolecules: Benefits and limitations in assay range
11 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Amgen (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago